Biologics Contract Development Market (2023 - 2030) Size, Share & Trends Analysis Report By Source (Mammalian, Microbial), By Service Type, By Indication (Oncology, Immunological Disorders), By Region And Segment Forecasts
- Report Summary
- Table of Contents
- Interactive Charts
- Methodology
- Download FREE Sample
-
Download Sample Report
Market Segmentation
- Biologics Contract Development Source Outlook (Revenue, USD Million, 2018 - 2030)
- Mammalian
- Microbial
- Others
- Biologics Contract Development Service Outlook (Revenue, USD Million, 2018 - 2030)
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Biologics Contract Development Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Immunological Disorders
- Cardiovascular Disorders
- Hematological Disorders
- Others
- Biologics Contract Development Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- North America Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- North America Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- The U.S.
- U.S. Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- U.S. Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- U.S. Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- U.S. Biologics Contract Development Market, by Source
- Canada
- Canada Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Canada Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Canada Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Canada Biologics Contract Development Market, by Source
- Europe
- Europe Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Europe Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Europe Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- UK
- UK Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- UK Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- UK Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- UK Biologics Contract Development Market, by Source
- Germany
- Germany Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Germany Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Germany Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Germany Biologics Contract Development Market, by Source
- France
- France Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- France Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- France Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- France Biologics Contract Development Market, by Source
- Italy
- Italy Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Italy Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Italy Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Italy Biologics Contract Development Market, by Source
- Spain
- Spain Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Spain Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Spain Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Spain Biologics Contract Development Market, by Source
- Denmark
- Denmark Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Denmark Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Denmark Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Denmark Biologics Contract Development Market, by Source
- Sweden
- Sweden Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Sweden Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Sweden Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Sweden Biologics Contract Development Market, by Source
- Norway
- Norway Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Norway Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Norway Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Norway Biologics Contract Development Market, by Source
- Europe Biologics Contract Development Market, by Source
- Asia Pacific
- Asia Pacific Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Asia Pacific Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Asia Pacific Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Japan
- Japan Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Japan Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Japan Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Japan Biologics Contract Development Market, by Source
- China
- China Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- China Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- China Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- China Biologics Contract Development Market, by Source
- India
- India Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- India Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- India Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- India Biologics Contract Development Market, by Source
- Australia
- Australia Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Australia Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Australia Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Australia Biologics Contract Development Market, by Source
- South Korea
- South Korea Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- South Korea Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- South Korea Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- South Korea Biologics Contract Development Market, by Source
- Thailand
- Thailand Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Thailand Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Thailand Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Thailand Biologics Contract Development Market, by Source
- Asia Pacific Biologics Contract Development Market, by Source
- Latin America
- Latin America Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Latin America Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Latin America Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Brazil
- Brazil Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Brazil Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Brazil Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Brazil Biologics Contract Development Market, by Source
- Mexico
- Mexico Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Mexico Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Mexico Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Mexico Biologics Contract Development Market, by Source
- Argentina
- Argentina Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Argentina Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Argentina Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Argentina Biologics Contract Development Market, by Source
- Colombia
- Colombia Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Colombia Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Colombia Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Colombia Biologics Contract Development Market, by Source
- Latin America Biologics Contract Development Market, by Source
- Middle East & Africa
- Middle East & Africa Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Middle East & Africa Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Middle East & Africa Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- South Africa
- South Africa Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- South Africa Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- South Africa Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- South Africa Biologics Contract Development Market, by Source
- Saudi Arabia
- Saudi Arabia Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Saudi Arabia Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Saudi Arabia Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Saudi Arabia Biologics Contract Development Market, by Source
- UAE
- UAE Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- UAE Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- UAE Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- UAE Biologics Contract Development Market, by Source
- Kuwait
- Kuwait Biologics Contract Development Market, by Source
- Microbial
- Mammalian
- Others
- Kuwait Biologics Contract Development Market, by Service
- Cell Line Development
- Microbial
- Mammalian
- Others
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- Impurity, isolation, & identification
- Physicochemical characterization
- Pharmaceutical analysis
- Others
- By Product
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Cell Line Development
- Kuwait Biologics Contract Development Market, by Indication
- Oncology
- Immunological disorders
- Cardiovascular disorders
- Hematological disorders
- Others
- Kuwait Biologics Contract Development Market, by Source
- Middle East & Africa Biologics Contract Development Market, by Source
- North America Biologics Contract Development Market, by Source
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
Get Free Sample Report
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
